- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07940322
Moses Technology vs Vapor Tunnel in Low Power Laser Lithotripsy (MT VT)
Double Blind Randomized Controlled Trial Comparing Two Distinct Pulse Modulation Modes in Low Power Laser Lithotripsy
The goal of this clinical study is to compare two different laser settings used to break up kidney and ureter stones during surgery. The study will include adults with kidney or ureter stones who are scheduled to undergo a procedure in which an endoscope is passed through the urinary tract and a laser is used to break the stones into smaller pieces.
The main question is whether one laser setting can break up stones using less energy than the other, while maintaining similar treatment effectiveness and safety.
A total of 110 participants will be randomly assigned to one of two groups:
- One group will undergo stone treatment using Moses Technology.
- The other group will undergo stone treatment using Vapor Tunnel.
Both methods use a laser to break stones into smaller pieces. The study will compare the amount of laser energy used in relation to the size of the stone. Researchers will also assess the duration of the procedure, how completely the stones are cleared, the movement of stones during surgery, and any complications.
The findings may help urologists understand which laser setting is more efficient and whether it offers advantages during the treatment of kidney and ureter stones.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Polyvios Arseniou
- Telefonnummer: 00306987553988
- E-mail: parseniou136@gmail.com
Undersøgelse Kontakt Backup
- Navn: Lazaros Tzelves
- Telefonnummer: 00306944104974
- E-mail: lazarostzelves@gmail.com
Studiesteder
-
-
Attica
-
Marousi, Attica, Grækenland, 15126
- 2nd Department of Urology, Sismanogleio General Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- kidney/ureter stone
- maximum stone diameter 5-20 mm (CT)
- any stone composition
- recent CT (3 months prior to procedure)
- indication/no contraindications for laser lithotripsy
- negative urine culture/adequate antibiotic preparation
- informed consent
Exclusion Criteria:
- pregnancy
- inability/unwillingness to provide informed consent
- radiolucent stones
- ipsilateral urinary tract anatomical abnormalities
- previous non-endoscopic surgery on the urinary tract
- active urinary tract infection
- acute kidney injury
- bleeding disorders
- inability to discontinue antithrombotic medication when required for the procedure
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Moses Technology
|
Laser lithotripsy using Moses Technology pulse modulation by Lumenis Pulse 120H Ho:YAG laser system, that produces a two-part laser pulse. The first low-energy part produces a vapor cavity through which the second high-energy part is transmitted to the stone without energy loss, increasing laser efficacy.
Andre navne:
|
|
Aktiv komparator: Vapor Tunnel
|
Laser lithotripsy using Vapor Tunnel pulse modulation by Quanta Cyber Ho Ho:YAG laser system, which creates one low-power long-length laser pulse that prevents stone retropulsion.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Laser efficacy
Tidsramme: During ureteroscopic procedure
|
Total energy delivered by the Ho:YAG laser during stone lithotripsy, divided by the preoperative stone volume measured on computed tomography (CT). The result will be expressed in joules per cubic millimeter (J/mm³). |
During ureteroscopic procedure
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Laser-on time
Tidsramme: During ureteroscopic procedure
|
The cumulative duration of laser activation during stone lithotripsy, measured in minutes and recorded by the laser system. |
During ureteroscopic procedure
|
|
Operative time
Tidsramme: During ureteroscopic procedure
|
The total duration of the ureteroscopic procedure, measured in minutes from the beginning to the completion of the surgical procedure. |
During ureteroscopic procedure
|
|
Total energy
Tidsramme: During ureteroscopic procedure
|
The cumulative energy delivered by the Ho:YAG laser during stone lithotripsy, measured in joules (J) and recorded by the laser system. |
During ureteroscopic procedure
|
|
Lithotripsy rate
Tidsramme: During ureteroscopic procedure
|
Lithotripsy rate calculated as the preoperative stone volume, measured on CT in cubic millimeters, divided by the total laser activation time in seconds. Results will be expressed in mm³/s. |
During ureteroscopic procedure
|
|
Stone-free rate
Tidsramme: One month after ureteral stent removal (ureteral stent removal typically removed 7-10 days after discharge)
|
The proportion of patients with no residual stone fragments larger than 3 mm on postoperative computed tomography (CT). |
One month after ureteral stent removal (ureteral stent removal typically removed 7-10 days after discharge)
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Intraoperative complications
Tidsramme: During ureteroscopic procedure
|
The proportion of patients experiencing one or more complications during the ureteroscopic procedure, including their type and nature. |
During ureteroscopic procedure
|
|
Postoperative complications
Tidsramme: Within 30 days after the ureteroscopic procedure
|
The proportion of patients experiencing postoperative complications, including their type and severity, classified according to the Clavien-Dindo classification system. |
Within 30 days after the ureteroscopic procedure
|
|
Length of hospital stay
Tidsramme: From hospital admission until discharge
|
The duration of hospitalization, calculated as the number of days from hospital admission to hospital discharge. |
From hospital admission until discharge
|
|
Stone retropulsion
Tidsramme: During ureteroscopic procedure
|
Surgeon-assessed stone retropulsion during laser lithotripsy, evaluated according to the distance of stone displacement, frequency of retropulsion events, and impact of retropulsion on the completion of stone fragmentation. |
During ureteroscopic procedure
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Publikationer og nyttige links
Generelle publikationer
- Ventimiglia E, Traxer O. What Is Moses Effect: A Historical Perspective. J Endourol. 2019 May;33(5):353-357. doi: 10.1089/end.2019.0012.
- Mullerad M, Aguinaga JRA, Aro T, Kastin A, Goldin O, Kravtsov A, Assadi A, Badaan S, Amiel GE. Initial Clinical Experience with a Modulated Holmium Laser Pulse-Moses Technology: Does It Enhance Laser Lithotripsy Efficacy? Rambam Maimonides Med J. 2017 Oct 16;8(4):e0038. doi: 10.5041/RMMJ.10315.
- Ulvik O, AEsoy MS, Juliebo-Jones P, Gjengsto P, Beisland C. Thulium Fibre Laser versus Holmium:YAG for Ureteroscopic Lithotripsy: Outcomes from a Prospective Randomised Clinical Trial. Eur Urol. 2022 Jul;82(1):73-79. doi: 10.1016/j.eururo.2022.02.027. Epub 2022 Mar 14.
- Terry RS, Ho DS, Scialabba DM, Whelan PS, Qi R, Ketterman BT, Preminger GM, Zhong P, Lipkin ME. Comparison of Different Pulse Modulation Modes for Holmium:Yttrium-Aluminum-Garnet Laser Lithotripsy Ablation in a Benchtop Model. J Endourol. 2022 Jan;36(1):29-37. doi: 10.1089/end.2021.0113. Epub 2021 Oct 29.
- Rico L, Contreras P, Blas L, Butori S, Martinez E, Proietti S, Giusti G, Ameri C. Dusting efficacy between the regular setting of holmium laser (Ho:YAG) versus Vapor Tunnel pulse modality for non-complex kidney stones. Lasers Med Sci. 2023 Jul 28;38(1):168. doi: 10.1007/s10103-023-03828-9.
- Kim K, Seo YS, Chung PS, Eom JB. Analysis of lithotripsy efficiency and stone retropulsion displacement according to pulse characteristics of Ho: YAG laser with Moses effect. Lasers Surg Med. 2024 Feb;56(2):197-205. doi: 10.1002/lsm.23743. Epub 2023 Nov 30.
- Corsini C, Robesti D, Villa L, Montorsi F, Pietropaolo A, Panthier F, Sierra A, Juliebo-Jones P, Kwok JL, Tsaturyan A, Contreras P, Fossati N, Gallina A, Xavier Keller E, Knoll T, Kartalas Goumas I, Somani BK, Traxer O, Salonia A, Ventimiglia E. Is Pulse Modulation the Future of Laser Technology in Endourology: Evidence from a Literature Review - Section of EAU Endourology. Eur Urol Focus. 2025 Mar;11(2):347-355. doi: 10.1016/j.euf.2024.10.009. Epub 2024 Nov 13.
- Black KM, Aldoukhi AH, Teichman JMH, Majdalany SE, Hall TL, Roberts WW, Ghani KR. Pulse modulation with Moses technology improves popcorn laser lithotripsy. World J Urol. 2021 Jun;39(6):1699-1705. doi: 10.1007/s00345-020-03282-0. Epub 2020 Jun 6.
- Aldoukhi AH, Roberts WW, Hall TL, Ghani KR. Watch Your Distance: The Role of Laser Fiber Working Distance on Fragmentation When Altering Pulse Width or Modulation. J Endourol. 2019 Feb;33(2):120-126. doi: 10.1089/end.2018.0572.
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Mandlige urogenitale sygdomme
- Calculi
- Patologiske Tilstande, Anatomiske
- Urologiske sygdomme
- Urogenitale sygdomme hos kvinder
- Kvinders urogenitale sygdomme og graviditetskomplikationer
- Patologiske tilstande, tegn og symptomer
- Urinvejsregning
- Urolithiasis
- Terapeutik
- Kirurgiske procedurer, operative
- Laserterapi
- Ablationsteknikker
- Ultralyds kirurgiske procedurer
- Lithotripsy
- Lithotripsi, Laser
Andre undersøgelses-id-numre
- 88866-24/7/2026
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .